Search research articles
Contact Us
Filters
Showing results (41-50 of 97) with videos related to
Page
of 10
Sort By:
Biological Psychiatry
|
July 15, 1990
Hunger in humans induced by MK-329, a specific peripheral-type cholecystokinin receptor antagonist
O M Wolkowitz, B Gertz, H Weingartner, et al.
The American Journal of Psychiatry
|
August 1, 1996
Dexamethasone for depression
O M Wolkowitz, V I Reus, F Manfredi, et al.
Lancet (London, England)
|
October 5, 1991
Specificity of memory impairments with triazolam use
H J Weingartner, M J Eckardt, D W Hommer, et al.
Archives of General Psychiatry
|
June 1, 1990
Circadian variation of plasma homovanillic acid levels is attenuated by fluphenazine in patients with schizophrenia
A R Doran, R Labarca, O M Wolkowitz, et al.
Journal of Affective Disorders
|
March 1, 1986
Pre- and post-dexamethasone plasma ACTH levels in depressed patients and normal controls
A Roy, P Gold, D Pickar, et al.
Life Sciences
|
October 19, 1987
Prednisone decreases CSF somatostatin in healthy humans: implications for neuropsychiatric illness
O M Wolkowitz, D R Rubinow, A Breier, et al.
The American Journal of Psychiatry
|
April 1, 1989
High prevalence of visual hallucinations in research subjects with chronic schizophrenia
H S Bracha, O M Wolkowitz, J B Lohr, et al.
Neuropsychobiology
|
January 1, 1988
Alternate-day corticosteroid treatment, mood and plasma HVA in patients with systemic lupus erythematosus
R T Joffe, O M Wolkowitz, D R Rubinow, et al.
Brain Research
|
May 2, 1998
Partial reversal of stress-induced behavioral sensitization to amphetamine following metyrapone treatment
M S Reid, L B Ho, B K Tolliver, et al.
The American Journal of Psychiatry
|
December 1, 1986
Serum antibodies to Epstein-Barr virus in patients with major depressive disorder
J D Amsterdam, W Henle, A Winokur, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 97) with videos related to
Sort By:
Page
of 10
Biological Psychiatry
|
July 15, 1990
Hunger in humans induced by MK-329, a specific peripheral-type cholecystokinin receptor antagonist
O M Wolkowitz, B Gertz, H Weingartner, et al.
The American Journal of Psychiatry
|
August 1, 1996
Dexamethasone for depression
O M Wolkowitz, V I Reus, F Manfredi, et al.
Lancet (London, England)
|
October 5, 1991
Specificity of memory impairments with triazolam use
H J Weingartner, M J Eckardt, D W Hommer, et al.
Archives of General Psychiatry
|
June 1, 1990
Circadian variation of plasma homovanillic acid levels is attenuated by fluphenazine in patients with schizophrenia
A R Doran, R Labarca, O M Wolkowitz, et al.
Journal of Affective Disorders
|
March 1, 1986
Pre- and post-dexamethasone plasma ACTH levels in depressed patients and normal controls
A Roy, P Gold, D Pickar, et al.
Life Sciences
|
October 19, 1987
Prednisone decreases CSF somatostatin in healthy humans: implications for neuropsychiatric illness
O M Wolkowitz, D R Rubinow, A Breier, et al.
The American Journal of Psychiatry
|
April 1, 1989
High prevalence of visual hallucinations in research subjects with chronic schizophrenia
H S Bracha, O M Wolkowitz, J B Lohr, et al.
Neuropsychobiology
|
January 1, 1988
Alternate-day corticosteroid treatment, mood and plasma HVA in patients with systemic lupus erythematosus
R T Joffe, O M Wolkowitz, D R Rubinow, et al.
Brain Research
|
May 2, 1998
Partial reversal of stress-induced behavioral sensitization to amphetamine following metyrapone treatment
M S Reid, L B Ho, B K Tolliver, et al.
The American Journal of Psychiatry
|
December 1, 1986
Serum antibodies to Epstein-Barr virus in patients with major depressive disorder
J D Amsterdam, W Henle, A Winokur, et al.
Page
of 10